ahlam1399
04-13-2016, 01:34 AM
FDA panel votes against approving Clovis?s cancer drug on current data
(Reuters) - An independent panel of experts advising the U.S. Food and Drug Administration recommended that Clovis Oncology Inc's lung cancer drug **t be approved based on existing trial data.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=rWpE1HS6X4g:OnZqvVHFoAw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rWpE1HS6X4g:OnZqvVHFoAw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=rWpE1HS6X4g:OnZqvVHFoAw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rWpE1HS6X4g:OnZqvVHFoAw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=rWpE1HS6X4g:OnZqvVHFoAw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/rWpE1HS6X4g
(Reuters) - An independent panel of experts advising the U.S. Food and Drug Administration recommended that Clovis Oncology Inc's lung cancer drug **t be approved based on existing trial data.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=rWpE1HS6X4g:OnZqvVHFoAw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rWpE1HS6X4g:OnZqvVHFoAw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=rWpE1HS6X4g:OnZqvVHFoAw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rWpE1HS6X4g:OnZqvVHFoAw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=rWpE1HS6X4g:OnZqvVHFoAw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/rWpE1HS6X4g